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Abstract 
Purpose: To develop a solid phase extraction (SPE) method that utilizes reverse-phase high 
performance liquid chromatography (RP-HPLC) to determine mitragynine (MG) in rat and human urine, 
and to investigate the influence of caffeine (CF) on urinary excretion of MG in rats.  
Methods: A two-dimensional wash-elute study was conducted using Oasis® HLB cartridge. The 
optimized SPE procedures consisted of washing with 5 and 70 % methanol containing 2 % ammonium 
hydroxide and eluting with methanol containing 2 % acetic acid. The SPE-HPLC method was validated 
according to United States Food and Drug Administration guidelines. Two groups of rats were used for 
the study and received an oral administration of either alkaloid extract (AE) of kratom (100 mg/kg), or 
AE (100 mg/kg) combined with CF (25 mg/kg).  The 24-h urine samples after administration were 
analyzed using the developed method for the content of MG excreted.  
Results: Validation indicate good linearity (r > 0.9991) and high precision in rat (1.18 - 5.97) and human 
urine (0.67 - 3.41). Accuracy for rat and human urine ranged from -9.11 - 19.64 and -7.20 - 13.72 %, 
respectively. Recovery of MG ranged from 92.75 - 100.83 %. Co-administration of AE and CF 
significantly increased urinary excretion of MG. 
Conclusion: The developed SPE method is simple, fast and reliable, and can be suitably applied to 
pharmacokinetic studies  
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Kratom (Mitragyna speciosa Korth.) is a native 
plant in Southeast Asian countries including 
Thailand.  Leaves from kratom have been 
traditionally used for curing conditions such as 
diarrhea and muscle pain.  It possesses 
psychoactive properties and opium-like effects 
[1].  In Thailand, kratom use is illegal as it is 
arranged in Category V of the Narcotics Act B.E. 
2522 (1979). Kratom abuse is common in 
southern Thailand among adolescents for 
recreation [2]. A common form of ingestion is a 
self-prepared ‘4 x 100’ cocktail which composes 
of boiled leaf extract, cola drinks, and codeine 
cough mixture.  The other additives include 
anxiolytic, antidepressant, and analgesic drugs, 
mosquito coil powder, fluorescent light bulb 
powder, road paint, and pesticides.  These toxic 
substances are added with a suggestion for 
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enhancing the cocktail’s effects without scientific 
support [3].  
 
Illegal use of kratom can be notified when 
mitragynine (MG), a major indole alkaloid in 
kratom leaves, is presented in urine or plasma of 
suspects.  A simple, specific, and sensitive 
method is needed. To date, several 
chromatographic techniques for determination of 
MG in biological matrices have been established. 
These include gas chromatography coupled with 
mass spectrometry (GC-MS) [4,5], ultra-high 
performance liquid chromatography (UHPLC)-
MS [6,7], LC-MS [8], and LC-MS-MS [9,10]. 
Regarding to the field of bioanalytical research, 
these sophisticate methods are so sensitive and 
specific that can replace the ordinary detection 
systems including HPLC-ultraviolet (UV) 
detection.  In Thailand, GC- and LC-MS were 
used in most laboratories of governmental 
agencies responsible for narcotics analytical 
development and screening. 
 
However, instrument availability is limited by its 
cost, the HPLC-UV detection with simple and 
effective sample preparation method is still 
necessary. This study therefore aimed to develop 
the simple solid phase extraction (SPE) 
procedure for determining MG in urine samples.  
Since several ingredients are present in kratom 
cocktail, the interaction between MG and other 
ingredients such as caffeine (CF) has not been 
reported. This study was also purposed to 
investigate the effect of CF on urinary excretion 
of MG in rats. The SPE method developed in this 






Methanol (HPLC grade) was from Mallinckrodt 
Baker Inc., USA. Deionized water was produced 
by a Milli-Q plus 185 Water Purification System 
from Millipore corp., USA.  Other chemicals were 
analytical grade. 
 
MG and kratom alkaloid extract 
 
Leaves of kratom were obtained from the Police 
Forensic Science Center 9, Songkhla, Thailand, 
and were extracted to obtain crude alkaloids 
extract (AE) and MG as previously described 
[11].  Dried leaves were extracted with methanol 
followed by chloroform to obtain the AE. The MG 
was isolated from the AE by using silica gel 
column chromatography. Then, the MG was 
identified by mass spectrometer and nuclear 
magnetic resonance spectroscopy. 
  
Preparation of standard solutions 
 
Pure methanol was used to prepare a stock 
solution of MG (1 mg/mL) which was further 
diluted to obtain working solutions (0.5-100 
g/mL).  Calibration standard solutions were 
prepared by adding working solutions to blank 
urine samples resulting to the final 
concentrations of 0.1, 0.5, 1 5 and 10 g/mL. 
 
Chromatographic method  
 
An Agilent 1200 Series HPLC system coupled 
with a diode array detector (Agilent, USA) was 
used. Data were processed using Chemstation 
Software System Agilent, USA. Chromatography 
was conditioned as the previous report [11].  
Sunfire C18 (250  4.6 mm i.d., 5 m), a 
separation column,  and Sentry guard columns 
(20  4.6 mm i.d., 5 m) from Waters (USA) was 
equilibrated at 35  1 C.  Methanol-water mobile 
phase (80:20, v/v) was flowed at 0.8 mL/min. A 





Oasis® HLB cartridges (1 mL/30 mg) (Waters 
Corporation, USA) were divided into 2 sets (11 of 
each) and subjected to passing with methanol-
water mixtures (0, 10, 20, 30, 40, 50, 60, 70, 80, 
90 and 100 %v/v) containing either 2 % 
ammonium hydroxide or 2 % acetic acid as a 
solvent. The cartridges were preconditioned with 
methanol and equilibrated with deionized water 
(1 mL).   
 
Blank- and MG-spiked samples (10 µg/mL, 1 mL) 
(n = 5) were loaded.  The cartridges were passed 
with the solvents (1 mL).  The eluate was 
collected separately and evaporated to dryness 
at 55 oC using a CentriVap Concentrator 
(Labconco, MO, USA). The residue was 
reconstituted with methanol (1 mL) for HPLC 
injection.  
 
Urine sample extraction 
 
The optimized SPE condition was used for 
extraction. After precondition and equilibration, 
the urine samples (1 mL) were loaded onto the 
cartridges.  The cartridges were washed with 1 
mL of 5 % methanol containing 2 % ammonium 
hydroxide followed by 1 mL of 70 % methanol 
containing 2 % ammonium hydroxide. The 
analyte was eluted with 1 mL of 100% methanol 
containing 2 % acetic acid. The eluate was 
collected, evaporated and reconstituted for HPLC 
analysis. 
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Method validation  
 
Validation was performed to determine linearity, 
precision, accuracy, recovery, and lower limit of 
quantification (LLOQ) in accordance with United 
States of Food and Drug Administration (USFDA) 
guidelines [12].  Urine of rats and human 
volunteers (n=5) were used.  Peak area-
concentration curve of MG was plotted and 
subjected to regression analysis to obtain 
calibration equation and correlation coefficient 
(r). Precision was indicated as coefficient of 
variation (CV) and accuracy was shown as 
deviation (DEV) .   LLOQ was the lowest 
concentration measured with acceptable 
precision and accuracy. 
 




Adult male Wistar rats (n=12, 230-250 g) were 
obtained from the Southern Laboratory Animal 
Facility, Prince of Songkla University and carried 
out in accordance with the guidelines of the 
National Research Council of Thailand based on 
the International Guiding Principles for 
Biomedical Research Involving Animals [13]. The 
study was approved by Animal Ethics 





Two groups of rats (6 each) orally received either 
a one dose of AE (100 mgkg), or AE (100 
mgkg) concomitant with CF (25 mgkg). AE was 
dissolved in pure propylene glycol, while CF was 
dissolved in deionized water. 
 
Rats were housed individually in a metabolic 
cage (Techniplast, USA). Urine was collected 8 
h before and at 8, 16, and 24 h after drug 
administration. Samples were centrifuged at 
2000g for 15 min at 4 C.  Supernatant was 




Peak areas, recovery of MG and validation 
parameters were expressed as mean ± SD.  
Percent urinary excretion of MG is expressed as 
mean ± SE and compared by Student’s t-test. 
Differences were considered significant at p < 







The efficiency of mobile phase for washing and 
eluting the cartridges was evaluated based on 
peak area of MG.  When the cartridges were 
passed with 0 – 80 % methanol-water mixtures 
containing 2 % ammonium hydroxide, no MG 
was eluted (Figure 1A). MG was slightly (23 %) 
eluted with 90 % methanol-base mixture and 
mostly with 100 % methanol-base mixture 
resulting to 133 % recovery of extraction. 
 
In contrast, when the cartridges were passed 
with 0 – 40 % methanol-water mixture containing 
2 % acetic acid, no MG was detected (Figure 
1B). At 50 % and above, MG was progressively 
eluted reaching the maximum at 90 % methanol 
mixture.  However, the peak of separation was 
asymmetrical and the recovery was 113 %.  With 
100 % methanol, the peak of separation was 




Figure 1: Peak areas and recovery (mean ± SD, n = 5) of MG in rat urine (10 µg/mL) after passing 
the cartridges with 0 – 100 % methanol-water mixture with acid-base modification; (A) 2 % ammonium 
hydroxide; (B) 2 % acetic acid 
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The effects of single and double passing of the 
cartridges with low and high percentages of 
methanol mixtures containing 2 % ammonium 
hydroxide were compared.  Single passing with 5 
% methanol-base mixture caused many unknown 
peak interferences (Figure 2A). Single passing 
with 70 % methanol-base mixture resulted to 
lesser interferences and sharp peak of MG 
(Figure 2B).  Passing with 5 % methanol-followed 
by 70% methanol-base mixture eliminated most 
interference (Figure 2C). According to the 
results, the SPE procedure was therefore 
composed of washing with 5 % methanol-
followed by 70 % methanol-water mixture 
containing 2 % ammonium hydroxide and eluting 





Figure 2: Chromatograms of MG after passing 
the cartridges with methanol-water mixture 
containing 2 % ammonium hydroxide; (A) single 
passing with 5 % methanol; (B) single passing 
with 70 % methanol; (C) double passing with 5 % 
followed by 70 % methanol 
 
Extraction of MG in rat and human urine 
 
MG in rat and human urine was extracted by 
using SPE technique developed in this study.  
MG, clearly separated from other components, 
was eluted at 9.38 min and 9.52 min in spiked rat 




The calibration curve for MG was linear with 
good correlation for both rat and human urine 
(Table 1). Precision and accuracy were 
acceptable. MG was completely recovered from 
urine samples. LLOQ was 0.1 g/mL. 
 
Application to MG excretion 
 
Urinary profiles of MG excretion in rats receiving 
either AE alone or AE combined with CF are 
presented in Figure 4. MG levels after 24 h were 
below the LLOQ.  After administration with AE 
alone, the amount of MG excreted during 0-24 h 
was 20.6-28.6%. The amounts excreted during 0 
- 8 h (5.1 - 22.6 %), 9 - 16 h (2.1 - 19.4 %) and 
17 - 24 h (3.1 - 7.1 %) were not significantly 
different. Co-administration of AE and CF 
resulted to a significant increase in MG excretion 





Sample extraction is an important step performed 
prior to determine MG by using LC or GC.  
Liquid-liquid extraction (LLE) is a conventional 
method used to extract MG from rat serum [11] 
and plasma [6], and human urine [9].  In recent 
works, SPE was used to extract MG from rat and 
human urine [5,8,10], plasma [14], and human 
whole blood [15]. SPE has more advantages 
than LLE, despite of the higher cost.  SPE not 
only extracts the analytes of interest but also 
removes the interferences in the matrices 
resulting to a cleaner extract. That leads to an 
increase in sensitivity, precision and accuracy of 
analysis.  Additionally, it requires smaller sample 
volume and produces fewer waste products [16]. 
 
In this study, Oasis® HLB was used to isolate MG 
from urine. The cartridge is a hydrophilic-
lipophilic balanced sorbent which is a 
macroporous copolymer consisting of the 
lipophilic divinylbenzene and the hydrophilic n-
vinylpyrrolidone. 
 
It is used for retaining hydrophobic compounds 
containing some hydrophilic functionality, 
especially aromatics.  It can bind basic, acidic, 
and neutral compounds whether polar or 
nonpolar.  Elution can be done with intermediate- 
and nonpolar solvents.   The macroporous 
cartridge needs less sorbents because it 
produces up to five times higher capacity  
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       Table 1: Validation parameters (mean± SD, n=5) of method for determination of MG in urine 
 
Parameter Rat urine Human urine 
Linearity Range (µg/mL) 0.1-10.0 0.5-10.0 
 Slope 108.04±8.30 107.83±7.25 
 y-intercept -5.96±13.95 -6.48±12.85 
 r 0.9991 0.9992 
Precision (% CV) intra-day 1.25-4.91 0.67-3.28 
 inter-day 1.18-5.97 0.74-3.41 
Accuracy (% DEV) intra-day (-)0.32-19.64 (-)2.70-13.72 
 inter-day (-)9.11-17.32 (-)7.20-4.88 
Recovery (%)  93.82-100.18 92.74-100.83 





Figure 3: Chromatogram of MG in spiked urine (10µg/mL); (A) blank rat urine; (B) spiked rat urine; (C) blank 
human urine; (D) spiked human urine 
 
 
Figure 4: Urinary excretion of MG (mean ± SE, n=6) in rats given a single oral dose of either AE (100 mg/kg) 
alone or AE (100 mg/kg) combined with CF (25 mg/kg) (AE+CF); *p < 0.05 when compared with AE alone 
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compared to silica-based reverse phase. 
Additionally, it has high pH stability across the 
range of 1 to 14 and high compatibility to organic 
solvent.   Modification of pH or solvent 
composition during washing and elution steps 
can easily clean the extract [17].  
  
The SPE method was optimized by performing a 
wash-elute study based on two-dimensional (2D) 
method to investigate the percentage of 
methanol in washing and elution solvents while 
the solvent pH is controlled. In reversed-phase 
LC and SPE, the analyte retention decreases 
when the organic concentration increases.  The 
retention of acidic and basic analytes is also 
dependent on the solvent pH.  Basic analytes are 
unionized at high pH and have high retention 
while they are ionized at low pH and exhibit low 
retention.  In contrast, acidic analytes are ionized 
at high pH and have low retention while they are 
unionized at low pH and exhibit high retention. 
For neutral analytes, the retention is independent 
on the pH.  
 
MG is a weak base, with intermediate 
lipophilicity, poorly soluble in water and basic 
media, but highly soluble in acidic media [18]. 
After sample loading, MG interacted with the 
sorbent and retained in the cartridge. When a 
solvent mixture of 0 – 80 % methanol-water and 
2 % ammonium hydroxide passed through the 
cartridge, MG was unionized and remained in the 
cartridge.  Only highly- and intermediate polar 
compounds both acid and neutral interferences 
were removed. When methanol concentration 
increased (90 -100 %), MG was eluted. 
Therefore, the mixture of 0 -80 % methanol-water 
with 2 % of ammonium hydroxide was probably 
used as a washing solvent.  The results showed 
that washing with low- followed by high 
percentage of methanol-basic mixture were 
preferable. The 5 % methanol-water mixture with 
2 % ammonium hydroxide removed most polar 
acidic and neutral interferences while the 70 % 
methanol-water mixture eliminated less polar 
compounds. That resulted to cleaner extract and 
lesser chromatographic noises.   
 
MG has intermediate lipophilicity and high 
solubility in acid environment in which it turned 
into an ionized form.  With intermediate polar 
solvent (50 % methanol mixture with 2 % acetic 
acid), MG was initiated to elute. With 100 % 
methanol-acid mixture, the elution was complete.  
Pure methanol containing 2 % acetic acid was 
the best elution solvent. Regarding to the results, 
MG was also eluted with 100 % methanol 
containing 2 % ammonium hydroxide, but the 
recovery was over 120% and the chromatogram 
was asymmetrical.  That might be because other 
non-polar compounds were co-eluted and 
detected at the same wavelength as MG.  
Hence, the 100 % methanol-base mixture was 
not chosen as the elution solvent. 
 
The optimized SPE method was coupled with the 
HPLC-UV technique to determine MG in rat and 
human urine.  All validation parameters were 
within the level of acceptance.  The SPE method 
resulted to complete extraction of MG from urine 
(>93 %).  Previous studies employed mixed-
mode cation-exchange sorbent cartridges 
(Oasis MCX and Isolute Confirm HCX), which 
was selective for basic analytes, to extract MG 
and other compounds from rat and human urine 
[5,8,10].  However, only one study reported 
extraction efficiency of MG of 73 % using Oasis 
MCX [10]. The present study showed that the 
universal HLB sorbent was sufficiently sensitive 
and selective for extraction of MG from urine.   
 
Among the studies using SPE method, the limits 
of detection (LOD) of MG varied depending on 
detection techniques and sample volume. Philipp 
et al [5] extracted urine sample by using Isolute 
Confirm HCX before detecting MG with GC-MS 
and reported the LOD of 0.1 g/mL. However, 3 
mL of urine was used to increase sensitivity of 
detection.  Tang et al [10] extracted 1 mL of urine 
with Oasis MCX before detection with UHPLC-
MS/MS and reported highly sensitive 
measurement with the LOD of 5 ng/mL. Levels of 
MG in urine of kratom users in previous reports 
ranged from 1 to >50,000 ng/mL [1,7].There are 
no quantitative data of urinary MG in Thai kratom 
users.  Only a prevalence study reported the 
presence of MG in urine of 0.9 % of Thai drivers 
with the level above 50 ng/mL [19]. The LLOQ of 
0.1 g/mL obtained in the present study is 
sufficiently and sensitively for screening most 
kratom users.  The employment of the optimized 
SPE method to the more sophisticate LC 
technique could enhance sensitivity of detection. 
 
Reports about an interaction between MG and 
other substances are rare.  CF may enhance 
action of MG or other alkaloids in kratom as 
indicated that an analgesic effect of AE from 
kratom could be potentiated by co-administration 
of CF and codeine [20]. The concomitant use of 
kratom and CF may cause overstimulation or 
elevated blood pressure, so this should be 
avoided [1]. MG showed toxicokinetic interaction 
with permethrin [21].  A single and multiple oral 
pretreatment with MG and kratom alkaloid extract 
delayed the elimination of permethrin in rats 
probably by inhibition of its hydrolysis, and this 
may increase the risk of permethrin neurotoxicity 
in kratom users.  
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The present study shows an increase in urinary 
excretion of MG in rats co-ingested with a single 
dose of CF.  MG is excreted into urine as both 
unchanged form and various metabolites after 
undergoing an extensive hepatic metabolism [3]. 
The increased excretion is probably because CF 
has a diuretic effect and can increase glomerular 
filtration and renal blood flow especially in the 
renal medulla [22] .  This study firstly 
demonstrated a pharmacokinetic alteration of 




A simple SPE method has been developed for 
extracting MG in urine. Employing this method to 
HPLC-UV detection resulted in an accurate, 
precise and sensitive analysis. This technique is 
suitable for the use in forensic science 
laboratories, poisons control center and other 
units responsible for identifying narcotic 
substances. This study provides an alternative 
method for laboratories that lack high technology 
equipment such as LC and GC, and it is useful 
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